Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2.
about
Nrf2 and redox status in prediabetic and diabetic patients.CXCL12 protects pancreatic β-cells from oxidative stress by a Nrf2-induced increase in catalase expression and activity.The Nrf2-ARE pathway is associated with Schisandrin b attenuating benzo(a)pyrene-Induced HTR cells damages in vitro.HO-1 Signaling Activation by Pterostilbene Treatment Attenuates Mitochondrial Oxidative Damage Induced by Cerebral Ischemia Reperfusion Injury.Pterostilbene inhibits inflammation and ROS production in chondrocytes by activating Nrf2 pathway.The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.Amelioration of streptozotocin‑induced pancreatic β cell damage by morin: Involvement of the AMPK‑FOXO3‑catalase signaling pathway.Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.Effect of resveratrol and pterostilbene on aging and longevity.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury.Biological Activities of Stilbenoids.Therapeutic Potential of Pterostilbene and Resveratrol on Biomechanic, Biochemical, and Histological Parameters in Streptozotocin-Induced Diabetic Rats.Association of NF-E2 Related Factor 2 (Nrf2) and inflammatory cytokines in recent onset Type 2 Diabetes Mellitus.Pterostilbene 4′-β-Glucoside Attenuates LPS-Induced Acute Lung Injury via Induction of Heme Oxygenase-1
P2860
Q34685338-3D8ED765-A863-4D75-8126-FEE9200EAFECQ38731410-84AF92C3-55CC-420A-8EA7-D79313135C0FQ38740553-81E3EC12-8625-4EC4-A7DD-5CFB8424122CQ38873745-12927FBC-96CA-48A8-B62B-21B67535B5C0Q41091842-7EF51E78-0ACF-4D52-AC3D-5929D42089E1Q41623135-1F479559-CE10-423F-A1D0-DCF2BAD86B54Q47212717-1627BD89-748B-4E06-A833-D853C11A239EQ47233632-B1AF8FFF-8B00-40CE-AB54-85BAB3230923Q47279730-B44CE5BC-F229-41F3-BF9F-4B28502F976FQ49385295-03E8732A-C77F-4D7C-9532-ECB1E36C6DA2Q51301800-4462238C-1FC5-4A7D-A99F-15656108747EQ55021760-5023CECF-AE20-4D81-81BE-1D37E9567078Q55251964-BA510D75-7832-45BE-9612-66EDC7683C95Q55338790-130E4153-6C78-45B6-B0F5-0D70A1F8933DQ58693674-D4194DB3-88C8-4B81-8902-839217C1DB2C
P2860
Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@en
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@nl
type
label
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@en
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@nl
prefLabel
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@en
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@nl
P2093
P2860
P356
P1476
Therapeutic potential of ptero ...... optosis mediated through Nrf2.
@en
P2093
Devibalan Shalini
Elango Bhakkiyalakshmi
Kunka Mohanram Ramkumar
Palanisamy Rajaguru
Ramasamy Paulmurugan
Thillai Veerapazham Sekar
P2860
P304
P356
10.1111/BPH.12577
P407
P577
2014-04-01T00:00:00Z